WASHINGTON, D.C. — A new higher-dose version of a widely used weight loss drug has been approved on an accelerated timeline, ...

According to the World Obesity Federation, as of 2024, about 3 billion people around the world were overweight or obese. However, not everyone who takes a GLP-1 medication loses weight. Past studies ...

March 19 (Reuters) - Novo Nordisk said on Thursday the U.S. Food and Drug Administration has approved a higher dose of its ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...

BOSTON — Starting in January, public workers and retirees enrolled in Group Insurance Commission plans will need to participate in a new program to maintain coverage for GLP-1 prescriptions as the ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. January has a funny way of making us ambitious.

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience ...

Moments after the ball drops on New Year’s Eve, people start talking about what they hope to accomplish in the new year — and weight loss is usually at the top of the list. It’s a common resolution, ...

California will end Medi-Cal coverage for popular weight-loss drugs like Wegovy starting Jan. 1, citing soaring pharmaceutical costs. Low-income residents losing coverage will be advised to rely on ...